Q4 2018 Investor Presentation slide image

Q4 2018 Investor Presentation

Working with Others to Raise Sleep as a Public Priority sleepscore verily labs... Consumer tech joint venture with Dr. Oz and Pegasus Capital World's first non- contact sleep tracking mobile app Shows people how they sleep, and how they can improve their sleep Sleep research joint venture with Verily¹ To study the health and financial impacts of untreated sleep apnea Based on research: Develop software solutions to help identify, diagnose, treat and manage those with OSA © 2018 ResMed | Q4 2018 Investor Presentation | 13. 1. Proposed sleep research JV, closing subject to regulatory review ResMed
View entire presentation